Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Tissue Eng Part A ; 25(11-12): 827-829, 2019 06.
Article in English | MEDLINE | ID: mdl-30838937

ABSTRACT

IMPACT STATEMENT: Medicinal plants are used by various traditional healers to alleviate the signs and symptoms associated with numerous diseases such as osteoarthritis, asthma, cancer, heart disease, tuberculosis, swollen ankles, bone fracture, malaria, convulsion, piles, hypertension, typhoid fever, diabetes, and anemia. Our research is relevant to communities that rely solely on traditional medicine for their well-being.


Subject(s)
Plants, Medicinal , Regenerative Medicine/methods , Regenerative Medicine/trends , Tissue Engineering/methods , Tissue Engineering/trends , Africa , Humans
2.
Leuk Res ; 37(6): 681-9, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23473917

ABSTRACT

SV40 footprints were detected in different lymphoproliferative disorders and in blood specimens of healthy donors. However, little is known on the ability of SV40 to infect/transform normal human B-lymphocytes. In this in vitro study, experimental SV40 infection and SV40 Tag transfection of normal human B-lymphocytes from healthy blood donors were carried out. In SV40 infected/transfected purified B-cells, during the time course analyses, viral DNA sequences were detected by PCR, while Tag mRNA and protein were revealed by RT-PCR and immunocytochemistry, respectively. Trypan blue and Alamar blue assays showed an increase in number of cells and cell viability of infected/transfected B-cells up to day 50, then a drastic and constant cell number reduction was observed in cultures. Approximately 50% of both infected and transfected B-cells appeared morphologically transformed. SV40 viral progeny and its titer from infected B-cells was determined by plaque assay in permissive CV-1 cells. Our data indicate that human B-cells can be efficiently infected by SV40, release a viral progeny, while at the same time are transformed. SV40 infected/Tag transfected B-cells may represent an experimental model of study for investigating new biomarkers and targets for innovative therapeutic approaches in human B-cell malignancies.


Subject(s)
Antigens, Polyomavirus Transforming/genetics , B-Lymphocytes/physiology , Cell Transformation, Viral , Simian virus 40/physiology , Animals , Antigens, Polyomavirus Transforming/physiology , B-Lymphocytes/metabolism , B-Lymphocytes/pathology , B-Lymphocytes/virology , Cell Line, Transformed , Cell Proliferation , Cell Survival/genetics , Cell Transformation, Viral/genetics , Cell Transformation, Viral/physiology , Cells, Cultured , Chlorocebus aethiops , Genetic Vectors/genetics , Humans , Polyomavirus Infections/pathology , Time Factors , Transfection , Tumor Virus Infections/pathology
3.
Exp Hematol ; 40(6): 466-76, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22421183

ABSTRACT

The relevance of viral infections to the onset and progression of human hematologic malignancies and other blood diseases is still a matter of active investigation. Purified human T lymphocytes isolated from the peripheral blood mononuclear cells of healthy blood donors were experimentally infected with simian virus 40 (SV40), a small DNA tumor virus. SV40-positive T lymphocytes extended their lifespan up to day 80 postinfection (PI). Expression of viral antigens, such as the large T antigen and the viral capsid protein VP1 from the early and late regions, respectively, was detected up to day 40 PI. SV40 viral progeny were continuously produced from day 10 to 40 PI. SV40 DNA sequences were detected in infected T cells for up to 80 days. Our data indicate that human T lymphocytes can be efficiently infected with SV40. Although T cells infected by SV40 were not immortalized, 30% of these lymphocytes appeared to be morphologically transformed with an enlarged T-cell shape. Our investigation provides a simple model for studying the interactions of human T lymphocytes with this small DNA tumor virus and it might represent an experimental tool for investigating new biomarkers and targets for innovative therapeutic approaches.


Subject(s)
Cell Survival , Simian virus 40/physiology , T-Lymphocytes/virology , Antigens, Polyomavirus Transforming/immunology , Cell Line, Transformed , Humans , Microscopy, Electron, Transmission , Simian virus 40/immunology , T-Lymphocytes/cytology
SELECTION OF CITATIONS
SEARCH DETAIL
...